-
Improving Glioblastoma Treatment
Phase I clinical trial finds adding a radiosensitizer may improve radiation’s ability to kill this fast-growing brain cancer.
by Thomas Celona
-
Quality of Life Across the Lifespan
As more people diagnosed with and treated for cancer live years beyond treatment, researchers look for ways to improve quality of life.
by Kevin McLaughlin
-
Results That Matter
Cancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.
by Eric Fitzsimmons
-
Genetic Testing for Women With Breast Cancer
New recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
by Laura Gesualdi-Gilmore
-
TIL Therapy Amplifies the Immune System’s Attack on Melanoma
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Dealing With Immediate Medical Test Results
Patients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.
by Taneia Surles
-
Empowering Pediatric Cancer Patients
After twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
-
Light at the End of the Tunnel for ASPS Patients
Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
CAR T-cell Therapy: Understanding the Warning and the Risks
The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
Overcoming Lung Cancer Stigma With Understanding
Shirley Muñoz wants to use her experience as a younger lung cancer patient to break down barriers to care for her community through translation and advocacy.
by Cameron Walker
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles